James C. Czirr

2012

In 2012, James C. Czirr earned a total compensation of $292.2K as Executive Chairman and Director at Galectin Therapeutics, a 91% decrease compared to previous year.

Compensation breakdown

Salary$212,503
Other$79,689
Total$292,192

Czirr received $212.5K in salary, accounting for 73% of the total pay in 2012.

Czirr also received $79.7K in other compensation.

Rankings

In 2012, James C. Czirr's compensation ranked 10,197th out of 11,487 executives tracked by ExecPay. In other words, Czirr earned more than 11.2% of executives.

ClassificationRankingPercentile
All
10,197
out of 11,487
11th
Division
Manufacturing
3,792
out of 4,253
11th
Major group
Chemicals And Allied Products
1,054
out of 1,198
12th
Industry group
Drugs
806
out of 920
12th
Industry
Pharmaceutical Preparations
617
out of 700
12th
Source: SEC filing on April 8, 2015.

Czirr's colleagues

We found three more compensation records of executives who worked with James C. Czirr at Galectin Therapeutics in 2012.

2012

Peter Traber

Galectin Therapeutics

Chief Executive Officer

2012

Harold Shlevin

Galectin Therapeutics

Chief Operating Officer

2012

Maureen Foley

Galectin Therapeutics

Chief Operating Officer

You may also like